HEMOSTASIS/COAGULATION ANALYZER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Stringent regulatory guidelines from governments across the globe are posing a major challenge for the growth of the global hemostasis and coagulation analyzer market. Various jurisdictions have implemented strict rules and protocols surrounding the sale, distribution and use of medical devices like hemostasis analyzers due to patient safety concerns. Complying with these regulations involves lengthy product approval processes, adherence to quality standards and post-market surveillance practices that substantially increase the cost and time taken for these advanced diagnostic platforms to reach the end users.

Market Opportunities – Rising Geriatric Population and Prevalence of Blood Disorders

The rising geriatric population and prevalence of blood disorders could provide significant opportunities for growth in the global hemostasis/coagulation analyzer market. As per United Nations data, the number of people aged 65 years and above is projected to grow from 727 million currently to over 1.5 billion by 2050 globally. With ageing comes increased vulnerability to various blood disorders and coagulation-related diseases. According to estimates by the World Health Organization, annual deaths due to cardiac failure are projected to rise to over 23 million worldwide by 2030. Many cardiac ailments have underlying issues related to blood coagulation abnormalities.